# ERLOTINIB HYDROCHLORIDE
> **ANDA208396** · Abbreviated New Drug Application (Generic) · Sponsor: APOTEX · Approved 2019-11-05
## Drug
- **FDA Application Number:** ANDA208396
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** ERLOTINIB HYDROCHLORIDE
- **Generic name:** Erlotinib Hydrochloride
- **Active ingredients:** ERLOTINIB HYDROCHLORIDE
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Discontinued
- **Sponsor:** APOTEX
- **First approval:** 2019-11-05
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208396)
---
*MORVS · CC0 1.0*